Literature DB >> 3933272

Detection of beta-lactamase activity with nitrocefin of multiple strains of various microbial genera.

J V Uri.   

Abstract

The production or presence of beta-lactamase(s) was studied by the rapid method utilizing the chromogenic cephalosporin compound nitrocefin in cultures of multiple strains belonging to the same genus as well as groups of microorganisms. The genera were: Staphylococcus spp., Streptococcus faecalis, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, indole-positive Proteus spp., Enterobacter spp., Serratia marcescens, rare Enterobacteriaceae, Pseudomonas aeruginosa, Haemophilus influenzae and Neisseria gonorrhoeae. With this sensitive and rapid assay for beta-lactamase, it was possible to verify and separate the beta-lactamase producing cultures from the non-producers and include the useful strains to on-going research, such as beta-lactam screen, beta-lactamase inhibitory study and lytic properties of beta-lactams. The data also provide evidence for the possible role of beta-lactamase(s) in the physiology, biochemistry and pathogenicity of bacterial strains. The nitrocefin method was found a very specific and extremely useful procedure for the detection and estimation of beta-lactamase activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3933272

Source DB:  PubMed          Journal:  Acta Microbiol Hung        ISSN: 0231-4622


  2 in total

1.  A design-constraint trade-off underpins the diversity in ecologically important traits in species Escherichia coli.

Authors:  Katherine Phan; Thomas Ferenci
Journal:  ISME J       Date:  2013-05-16       Impact factor: 10.302

2.  Fluorogenic D-amino acids enable real-time monitoring of peptidoglycan biosynthesis and high-throughput transpeptidation assays.

Authors:  Edward Hall; Garrett Booher; Brennan Murphy; Yen-Pang Hsu; Atanas D Radkov; Jacob Yablonowski; Caitlyn Mulcahey; Laura Alvarez; Felipe Cava; Yves V Brun; Erkin Kuru; Michael S VanNieuwenhze
Journal:  Nat Chem       Date:  2019-02-25       Impact factor: 24.427

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.